Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-069349
Date:2021-12-09
Issuer: AEGLEA BIOTHERAPEUTICS, INC. (AGLE)
Original Submission Date:

Reporting Person:

ALSPAUGH JONATHAN
C/O AEGLEA BIOTHERAPEUTICS, INC.
805 LAS CIMAS PARKWAY, SUITE 100 AUSTIN, TX 78746

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-12-09 P 50,000 a $3.72 90,372 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the reported price in column 4 is a weighted average price. these shares were purchased in multiple transactions at prices ranging from $3.64 to $3.94 per share, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
WhaleWisdom Logo

Elevate your investments